ada glp 1 recommendations WHO issues guidelines for GLP1 receptor agonists in obesity ada guidelines dpp4 and glp

Although GLP-1 medications are often discussed in the context of weight management or blood sugar control, they actually work directly on the digestive system

No adverse events, such as diabetic ketoacidosis (DKA) or genital infections, were reported during the follow-up period

Furthermore, the paper indicated that standard MyPlate guidance, typically based on a 2,000-calorie diet, may not be tailored for the lower caloric needs or specific nutritional challenges of individuals on GLP-1RA therapy

GLP-1 receptors are expressed primarily in pancreatic islets, the gastrointestinal tract, kidney, heart, and certain brain regions, with limited expression in skeletal muscle tissue

LAMP3 induces apoptosis and autoantigen release in Sjgrens syndrome patients